The Food and Drug Administration approved two new weight-loss drugs last summer, but neither has achieved blockbuster status, and industry analysts don't expect them to anytime soon.

Qsymia, manufactured by Vivus, has been available since last September. It's a combination product with two active ingredients - one that works to decrease appetite and another that helps increase feelings of fullness.

Register or login for access to this item and much more

All Employee Benefit News content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access